An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates

Anesthesia and Analgesia

Volumn 100, Issue 5, 2005, Pages 1276-1282

  Guzzetta, Nina A ^a,d   Miller, Bruce E ^a   Todd, Kathy ^b   Szlam, Fania ^a   Moore, Renee H ^c   Tosone, Steven R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Federal Reserve Bank of Atlanta   (United States)

^c EMORY UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; FIBRINOPEPTIDE A; HEPARIN; PROTHROMBIN; THROMBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; HEMODILUTION; HEPARINIZATION; HUMAN; INFANT; NEWBORN; PRIORITY JOURNAL; THROMBIN TIME;

ADOLESCENT; ADULT; AGE FACTORS; CARDIOPULMONARY BYPASS; CHILD; FIBRINOPEPTIDE A; HEPARIN; HUMANS; INFANT, NEWBORN; THROMBIN; WHOLE BLOOD COAGULATION TIME;

EID: 17744365791     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000149590.59294.3A     Document Type: Article

References (23)

1. Dietrich W. Reducing thrombin formation during cardiopulmonary bypass: Is there a benefit of the additional anticoagulant action of aprotinin? J Cardiovasc Pharmacol 1996;27:S50-7.
2. Slaughter TF, LeBleu TH, Douglas JM, et al. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology 1994;80:520-6.
3. Hirsh J. Mechanism of action and monitoring of anticoagulants. Semin Thromb Hemostas 1986;12:1-11.
4. Hashimoto K, Yamagishi M, Sasaki T, et al. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation. Ann Thorac Surg 1994;58:799-805.
5. Lemmer JH, Despotis GJ. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2002;123:213-7.
6. Despotis GJ, Vladimir L, Joist JH, et al. Antithrombin III during cardiac surgery: Effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation. Anesth Analg 1997;85:498-506.
7. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104.
8. Weitz JI, Hudoba M, Massel D, et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990;86:385-91.
9. Yin ET, Wessler S, Butler JV. Plasma heparin: A unique, practical, submicrogram-sensitive assay. J Lab Clin Med 1973;81:298-310.
10. Despotis GJ, Joist HJ, Hogue CW, et al. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost 1996;76:902-8.
11. Koster A, Fischer T, Praus M, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: Impact of heparin management. Anesthesiology 2002;97:837-41.
12. Chan A, Leaker M, Burrows F, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997;77:270-7.
13. Boisclair MD, Lane DA, Philippou H, et al. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1+2. Thromb Haemost 1993;70:253-8.
14. Schmidt B, Ofosu FA, Mitchell L, et al. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res 1989;25:405-8.
15. Andrew M, Schmidt B, Mitchell L, et al. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990;63:27-30.
16. Kern FH, Morana NJ, Sears JJ, et al. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992;54:541-6.
17. Vieira A, Berry L, Ofosu F. Heparin sensitivity and resistance in the neonate: an explanation. Thromb Res 1991;63:85-98.
18. Andrew M. Anticoagulation and thrombolysis in children. Tex Heart Inst J 1992;19:168-77.
19. Horkay F, Martin P, Rajah SM, et al. Response to heparinization in adults and children undergoing cardiac operations. Ann Thorac Surg 1992;53:822-6.
20. Dietrich W, Braun S, Spannagl M, et al. Low preoperative antithrombin activity causes reduced response to heparin in adults but not in infant cardiac-surgical patients. Anesth Analg 2001;92:66-71.
21. Spannagl M, Dietrich W, Beck A, et al. High dose aprotinin reduces prothrombin and fibrinogen conversion in patients undergoing extracorporeal circulation for myocardial revascularization. Thromb Haemost 1994;72:159-60.
22. Mossinger H, Dietrich W, Braun SL, et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003;75:430-7.
23. Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant? Thromb Haemost 1993;70:259-62.